JP2023532203A5 - - Google Patents
Info
- Publication number
- JP2023532203A5 JP2023532203A5 JP2022577556A JP2022577556A JP2023532203A5 JP 2023532203 A5 JP2023532203 A5 JP 2023532203A5 JP 2022577556 A JP2022577556 A JP 2022577556A JP 2022577556 A JP2022577556 A JP 2022577556A JP 2023532203 A5 JP2023532203 A5 JP 2023532203A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding portion
- storage
- pharmaceutical formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040589P | 2020-06-18 | 2020-06-18 | |
| US63/040,589 | 2020-06-18 | ||
| PCT/US2021/038016 WO2021257947A1 (en) | 2020-06-18 | 2021-06-18 | Activin a antibody formulations and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023532203A JP2023532203A (ja) | 2023-07-27 |
| JP2023532203A5 true JP2023532203A5 (https=) | 2024-06-21 |
| JP7850084B2 JP7850084B2 (ja) | 2026-04-22 |
Family
ID=77168377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022577556A Active JP7850084B2 (ja) | 2020-06-18 | 2021-06-18 | アクチビンａ抗体製剤及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12472253B2 (https=) |
| EP (1) | EP4168038A1 (https=) |
| JP (1) | JP7850084B2 (https=) |
| KR (1) | KR20230026407A (https=) |
| CN (1) | CN116322768A (https=) |
| AU (1) | AU2021293577A1 (https=) |
| BR (1) | BR112022025700A2 (https=) |
| CA (1) | CA3183316A1 (https=) |
| CL (1) | CL2022003586A1 (https=) |
| CO (1) | CO2023000264A2 (https=) |
| IL (1) | IL299103A (https=) |
| MX (1) | MX2022016403A (https=) |
| WO (1) | WO2021257947A1 (https=) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
| JP3100727B2 (ja) | 1992-01-23 | 2000-10-23 | 株式会社大協精工 | 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品 |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| JP3172057B2 (ja) | 1995-04-05 | 2001-06-04 | 株式会社大協精工 | ラミネートゴム栓 |
| JP3512349B2 (ja) | 1999-01-29 | 2004-03-29 | 株式会社大協精工 | 柱状ゴム要素の成形型 |
| US6949245B1 (en) | 1999-06-25 | 2005-09-27 | Genentech, Inc. | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| JP2002209975A (ja) | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| UA115789C2 (uk) | 2012-09-05 | 2017-12-26 | Трейкон Фармасутікалз, Інк. | Композиція антитіла до cd105 та її застосування |
| TW201920262A (zh) * | 2013-07-30 | 2019-06-01 | 美商再生元醫藥公司 | 抗活化素ａ之抗體及其用途 |
| US20160075772A1 (en) * | 2014-09-12 | 2016-03-17 | Regeneron Pharmaceuticals, Inc. | Treatment of Fibrodysplasia Ossificans Progressiva |
| WO2018009732A1 (en) | 2016-07-08 | 2018-01-11 | Regeneron Pharmaceuticals, Inc. | Anti-activin a antibodies and methods of use thereof for treating pulmonary arterial hypertension |
| MA46046A (fr) | 2016-08-29 | 2019-07-03 | Regeneron Pharma | Anticorps anti-gremlin-1 (grem1) et procédés d'utilisation de ces anticorps dans le traitement de l'hypertension artérielle pulmonaire |
| WO2018184692A1 (en) * | 2017-04-07 | 2018-10-11 | Ares Trading S.A. | Liquid pharmaceutical composition |
| CN111655288A (zh) * | 2017-11-16 | 2020-09-11 | 诺华股份有限公司 | 组合疗法 |
| MX2020008991A (es) * | 2018-03-01 | 2020-12-10 | Regeneron Pharma | Metodos para alterar la composicion corporal. |
-
2021
- 2021-06-18 BR BR112022025700A patent/BR112022025700A2/pt unknown
- 2021-06-18 KR KR1020237001524A patent/KR20230026407A/ko active Pending
- 2021-06-18 CN CN202180059660.5A patent/CN116322768A/zh active Pending
- 2021-06-18 WO PCT/US2021/038016 patent/WO2021257947A1/en not_active Ceased
- 2021-06-18 IL IL299103A patent/IL299103A/en unknown
- 2021-06-18 MX MX2022016403A patent/MX2022016403A/es unknown
- 2021-06-18 JP JP2022577556A patent/JP7850084B2/ja active Active
- 2021-06-18 US US17/351,354 patent/US12472253B2/en active Active
- 2021-06-18 AU AU2021293577A patent/AU2021293577A1/en active Pending
- 2021-06-18 CA CA3183316A patent/CA3183316A1/en active Pending
- 2021-06-18 EP EP21749377.4A patent/EP4168038A1/en active Pending
-
2022
- 2022-12-15 CL CL2022003586A patent/CL2022003586A1/es unknown
-
2023
- 2023-01-12 CO CONC2023/0000264A patent/CO2023000264A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023026536A (ja) | 補体のインヒビターによる発作性夜間血色素尿症患者の処置 | |
| JP5918246B2 (ja) | 抗インターロイキン−４受容体（ｉｌ−４ｒ）抗体を含有する安定化製剤 | |
| JP2022532927A5 (https=) | ||
| JP2022036932A5 (https=) | ||
| WO2015157286A1 (en) | Stable formulations for anti-cd19 antibodies and antibody-drug conjugates | |
| JP2024515968A5 (https=) | ||
| JP2020158505A5 (https=) | ||
| US12565526B2 (en) | Formulations of anti-RSV antibodies and methods of use thereof | |
| JP2022526292A5 (https=) | ||
| WO2019020069A1 (zh) | 一种sost抗体药物组合物及其用途 | |
| JP2024540226A5 (https=) | ||
| CN117159703B (zh) | 含抗lag-3抗体的药物组合物及其用途 | |
| RU2020111574A (ru) | Высококонцентрированные, маловязкие препараты ингибирующих masp-2 антител, наборы и способы лечения субъектов, страдающих атипическим гемолитическим синдромом | |
| JP2023502398A5 (https=) | ||
| JP2020531523A5 (https=) | ||
| JP2023532203A5 (https=) | ||
| JP2021501213A5 (https=) | ||
| JP2022527542A5 (https=) | ||
| JP2024501430A5 (https=) | ||
| KR20240100493A (ko) | 항-cd22 항체의 수성 제제 및 이의 용도 | |
| JP2024513835A5 (https=) | ||
| US12157764B2 (en) | Dosing regimen for treating influenza virus diseases | |
| CA3115708C (en) | Formulations of anti-rsv antibodies and methods of use thereof | |
| HK40102408A (zh) | 含抗lag-3抗体的药物组合物及其用途 | |
| HK40102408B (zh) | 含抗lag-3抗体的药物组合物及其用途 |